Category: Suicide and Self-Injury
Molly Adrian, Ph.D. (she/her/hers)
Associate Professor
University of Washington
Seattle, Washington
David Jobes, ABPP, Ph.D. (he/him/his)
Professor of Psychology
The Catholic University of America
Washington, District of Columbia
Tina Goldstein, Ph.D. (she/her/hers)
Associate Professor
University of Pittsburgh School of Medicine
Pittsburgh, PA, Pennsylvania
Michele Berk, Ph.D. (she/her/hers)
Assistant Professor
Stanford University
STANFORD, California
Sarah Danzo, Ph.D. (she/her/hers)
University of Washington
Seattle, Washington
Suicide is a leading cause of death for those aged 10-34 in the United States and a major public health concern among adolescents and young adults (AYA; Hedegaard et al., 2018). Importantly, suicides among AYA have increased over the last two decades with more deaths in 2017 than in any other year since 2000 (Miron et al., 2019). This trend emphasizes the critical need to identify factors that contribute to recovery, remission, and relapse of suicidal thoughts and behaviors (STB). Although research on risk factors for suicide is extensive, the field struggles to understand the course of STB and critical transitions to promote recovery over the course of development (Franklin et al., 2017; Large, Corderoy, & McHugh, 2021; Oppenheimer et al., 2022). Recent reviews outlining the research needs in suicide prevention have called for a developmental psychopathology approach that captures how STB develop and change over time (Oppenheimer, Glenn, & Miller, 2022). Fluctuations in STB suicide risk status are not well understood, even in high-risk groups (Franklin et al., 2017). The goal of the symposium is to bring together several studies focused on the etiology and treatment of STB, present the definitions utilized to identify recovery, remission, relapse and recurrence, and discuss strategies to promote recovery from STB during this developmental period.